Radiation Dose-Volume Effects in the Esophagus
Open Access
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 76 (3), S86-S93
- https://doi.org/10.1016/j.ijrobp.2009.05.070
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Predictors of Acute Esophagitis in Lung Cancer Patients Treated With Concurrent Three-Dimensional Conformal Radiotherapy and ChemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Long-Term Follow-Up of a Phase I/II Trial of Dose Escalating Three-Dimensional Conformal Thoracic Radiation Therapy with Induction and Concurrent Carboplatin and Paclitaxel in Unresectable Stage IIIA/B Non-small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Four-dimensional computed tomographic analysis of esophageal mobility during normal respirationInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Multivariable modeling of radiotherapy outcomes, including dose–volume and clinical factorsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancerRadiotherapy and Oncology, 2005
- Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01Journal of Clinical Oncology, 2005
- Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Tumour and Normal Tissue Responses to Fractionated Non-uniform Dose DeliveryInternational Journal of Radiation Biology, 1992